Your browser doesn't support javascript.
loading
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study.
Rampotas, Alexandros; Sockel, Katja; Panitsas, Fotios; Theuser, Catrin; Bornhauser, Martin; Hernani, Rafael; Hernandez-Boluda, Juan Carlos; Esquirol, Albert; Avenoso, Daniele; Tsirigotis, Panagiotis; Robin, Marie; Czerw, Tomasz; Helbig, Grzegorz; Roddie, Claire; Lambert, Jonathan; McLornan, Donal P.
Afiliación
  • Rampotas A; Department of Haematology and Cell Therapy, University College London Hospital NHS Foundation Trust, London, United Kingdom. Electronic address: a.rampotas@nhs.net.
  • Sockel K; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Germany.
  • Panitsas F; Department of Haematology, Laikon University Hospital, Athens, Greece.
  • Theuser C; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Germany.
  • Bornhauser M; Medical Clinic and Policlinic I, University Hospital Dresden, TU Dresden, Germany.
  • Hernani R; Haematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Hernandez-Boluda JC; Haematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.
  • Esquirol A; Department of Haematology, Hospital de la Santa creu i Sant Pau and Universitat Autonoma de Barcelona, Spain.
  • Avenoso D; Department of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Tsirigotis P; Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece.
  • Robin M; Service d'Hématologie-Greffe, Hôpital Saint-Louis, APHP, Université de Paris Cité, Paris, France.
  • Czerw T; Department of Haematology and Bone Marrow Transplantation, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
  • Helbig G; Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland.
  • Roddie C; Department of Haematology and Cell Therapy, University College London Hospital NHS Foundation Trust, London, United Kingdom.
  • Lambert J; Department of Haematology and Cell Therapy, University College London Hospital NHS Foundation Trust, London, United Kingdom.
  • McLornan DP; Department of Haematology and Cell Therapy, University College London Hospital NHS Foundation Trust, London, United Kingdom.
Transplant Cell Ther ; 29(11): 687.e1-687.e7, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37633414
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mielofibrosis Primaria / Enfermedad Injerto contra Huésped Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mielofibrosis Primaria / Enfermedad Injerto contra Huésped Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos